MIOX and obesity due to melanocortin 4 receptor deficiency: Additionally, MIOX has been reported to disrupt cellular energy homeostasis by inhibiting the AMPK/sirtuins/PGC-1α/YY-1 pathway, thereby aggravating obesity-associated renal tubular injury [39].